In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
Resources and Tools
Clinicians can now access up-to-date evidence-based office-based addiction treatment recommendations for treating opioid use disorder (OUD) on a smartphone app.
This policy brief identified states potentially at risk for an HIV or HCV outbreak and used data from multiple sources to examine rural-urban differences in 1) state-level infectious disease surveillance, prevention activities, and collaboration with stakeholders; 2) local health department-level
Because of naloxone’s ability to reverse opioid overdose and its ease of use, by July 15, 2017, all 50 states and the District of Columbia had passed legislation to improve naloxone access, as one strategy to reduce opioid overdose morbidity and mortality.
This webinar describes systemic barriers faced by patients with HIV and substance use disorders, and discusses steps providers can take to decrease these barriers and support integration of behavioral health and HIV public health interventions.
Keywords: HIV, substance use